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While immune cell adaptors regulate proximal T cell
signaling, direct regulation of the nuclear pore com-
plex (NPC) has not been reported. NPC has cyto-
plasmic filaments composed of RanGAP1 and
RanBP2 with the potential to interact with cyto-
plasmic mediators. Here, we show that the immune
cell adaptor SLP-76 binds directly to SUMO-
RanGAP1 of cytoplasmic fibrils of the NPC, and
that this interaction is needed for optimal NFATc1
and NF-kB p65 nuclear entry in T cells. Transmission
electron microscopy showed anti-SLP-76 cyto-
plasmic labeling of the majority of NPCs in anti-CD3
activated T cells. Further, SUMO-RanGAP1 bound
to the N-terminal lysine 56 of SLP-76 where the
interaction was needed for optimal RanGAP1-NPC
localization and GAP exchange activity. While the
SLP-76-RanGAP1 (K56E) mutant had no effect on
proximal signaling, it impaired NF-ATc1 and p65/
RelA nuclear entry and in vivo responses to OVA pep-
tide. Overall, we have identified SLP-76 as a direct
regulator of nuclear pore function in T cells.
INTRODUCTION
T cells express protein-tyrosine kinases and adaptors that inte-
grate signals for T cell activation (Rudd, 1999; Rudd et al.,
2010; Samelson, 2002; Smith-Garvin et al., 2009). Adaptors
possess binding sites and discrete modular domains that inte-
grate signals. Immune cell adaptors include SH2 domain con-
taining leukocyte protein of 76 kDa (SLP-76) (Jackman et al.,
1995; Smith-Garvin et al., 2009), linker for the activation of
T cells (LAT) (Zhang et al., 1998), and adhesion- and degranula-
tion-promoting adaptor protein (ADAP) (da Silva et al., 1997; Liu
et al., 1998; Musci et al., 1997). SLP-76 has a N-terminal sterile-a
motif (SAM), tyrosine motifs and a SH2 domain and is needed for
T cell differentiation and function (Jackman et al., 1995; Jordan840 Molecular Cell 59, 840–849, September 3, 2015 ª2015 The Authet al., 2003; Pivniouk et al., 1998). SLP-76-deficient T cells
show an impaired phospholipase Cg1 (PLCg1) activation and
calcium mobilization (Yablonski et al., 1998), while N-terminal
residues are phosphorylated by ZAP-70 (Bubeck Wardenburg
et al., 1996; Raab et al., 1997). Y-113 and Y-128 bind exchange
factor Vav1 and adaptor Nck (Bubeck Wardenburg et al., 1998;
Jackman et al., 1995;Wu et al., 1996), resting lymphocyte kinase
(Rlk) (Schneider et al., 2000), and inducible tyrosine kinase (Itk)
(Bunnell et al., 2000). SLP-76 binds to the SH3 domain of
PLCg1 (Grasis et al., 2010; Yablonski et al., 2001), while GADs
SH2 domain forms a complex with LAT (Zhang et al., 1998).
SLP-76 also forms microclusters (Bunnell et al., 2002; Yokosuka
et al., 2005), exerts feedback control on ZAP-70 (Liu et al., 2010),
and interacts with subsynaptic LAT clusters (Purbhoo et al.,
2010; Williamson et al., 2011). The SLP-76 SH2 domain binds
to ADAP (da Silva et al., 1997; Musci et al., 1997) and hematopoi-
etic progenitor kinase-1 (HPK-1) (Di Bartolo et al., 2007; Shui
et al., 2007). In turn, ADAP binds to adaptor SKAP1 (SKAP-55)
for integrin adhesion (Raab et al., 2010, 2011; Wang and Rudd,
2008).
SLP-76 is also needed downstream to activate transcription
factors NFAT (nuclear factor for the activation of T cells) and
NF-kB (nuclear factor kappa-light-chain-enhancer of activated
B cells) (Yablonski et al., 1998). NFAT possesses two basic nu-
clear localization sequences (NLSs) for nuclear import depen-
dent on dephosphorylation by calcineurin (Mu¨ller and Rao,
2010; Wu et al., 2007). Dephosphorylation unmasks nuclear-
location signals (Shibasaki et al., 1996). Similarly, NF-kB plays
roles in inflammation, cell activation, and differentiation (Ghosh
and Karin, 2002; Sen, 2011). Coreceptor CD28 and innate recep-
tors activate NF-kB transcription via different pathways in T cells
(Marinari et al., 2002; Thaker et al., 2015).
Nuclear transport is mediated by the nuclear pore complex
(NPC) (Chatel and Fahrenkrog, 2012; Hoelz et al., 2011). The
NPC is composed of more than 30 nucleoporins (Nups) needed
for anchorage and the formation of a central mesh in the channel
(Allen et al., 2008; D’Angelo and Hetzer, 2008). Intriguingly, eight
filaments extend into the cytoplasm comprised of RanBP2
(Nup358) and RanGAP1, the latter having GTPase activity for
GTP-Ran (Bischoff et al., 1994). This interaction requires the
ATP-dependent posttranslational conjugation of RanGAP1 withors
SUMO-1 (for small ubiquitin-related modifier) (Lee et al., 1998;
Mahajan et al., 1997). Ran binding to GTP causes importins to
release protein in the nucleus, while nonhydrolysable GTP accu-
mulates Ran-GTP at the filaments (Melchior et al., 1995).
RanBP2/RanGAP1 and associated SUMO1/Ubc9 form a multi-
subunit SUMOE3 ligase (Pichler et al., 2002;Werner et al., 2012).
SLP-76 microclusters at the cell surface translocate to the
perinuclear region of T cells (Bunnell et al., 2002). While adaptors
mediate TCRproximal signaling, direct regulation of theNPC has
not been reported. Here, we show that direct SLP-76 binding to
the SUMO-RanGAP1 of cytoplasmic filaments of the NPC is
required for the regulation of transcription factor entry into the
nucleus of T cells. Our findings identify a surprising direct mech-
anism of NPC regulation by an immune adaptor in T cells.
RESULTS
SLP-76 Localizes to the Nuclear Pore and Binds to
SUMO-RanGAP1
NPC fibrils could potentially interact with cytoplasmic signaling
proteins in T cells. Mouse DC27.10 T cells were anti-CD3 ligated
for 10 min and imaged by confocal fluorescence microscopy
(Figure 1A). Monoclonal antibody to NPC proteins (Mab414)
and anti-RanGAP1 stained the nuclear envelop around the
DAPI-stained nucleus (upper and middle panels). Anti-CD3-
induced endogenous SLP-76 microclusters overlapped with
RanGAP1 as detected by antibody staining (middle panel; right
expanded image). Immune-gold transmission electron micro-
scopy (TEM) using anti-SLP-76 showed labeling of the cyto-
plasmic site of the NPC in response to anti-CD3 ligation (lower
left versus right panel). Quantitation showed that anti-SLP-76
stained 13% of randomly selected NPCs with gold particles in
resting cells (n = 44) (Figure 1B). Remarkably, 76% of NPCs
had at least one gold particle within a distance of 130 nm from
the cytoplasmic ring in response to anti-CD3 ligation, (i.e., an
average of 0.84 particles per NPC of 100 randomly selected
NPCs with zero to three labels each). A total of 77% of labels
were cytoplasmic (n = 109), with an average distance of
35 nm from the cytoplasmic ring, a distance comparable to
RanGAP staining (histogram).
NPC cytoplasmic fibrils are comprised of RanBP2 and
RanGAP1 (Hutten et al., 2008). RanGAP1 exists as a nonsumoy-
lated 70 Kd and a 90 Kd sumoylated form that associates with
that NPC (Bernier-Villamor et al., 2002; Matunis et al., 1996).
Anti-SLP-76 coprecipitated a 90 Kd protein from mouse
DC27.10 T cells and preactivated human primary T cells as
recognized by anti-RanGAP1 blotting (Figure 1C, left panel,
lanes 2 and 3, and 4 and 5, respectively). Anti-CD3 ligation
increased coprecipitated RanGAP1 (upper panel, lane 3 versus
lane 2 and lane 5 versus lane 4). Occasionally, a smaller amount
of nonsumoylated RanGAP1 was apparent in the anti-SLP-76
precipitates (3/16 experiments). Specificity was shown by the
failure of anti-SKAP1 (right panel, lanes 5 and 6), anti-ADAP
(lanes 7 and 8), or anti-CARMA1 (lanes 9 and 10) to coprecipitate
RanGAP1. A time course showed that the optimal coprecipita-
tion of RanGAP1 was a relatively late event with maximal levels
at 10–20 min following anti-CD3 ligation (Figure 1D). Anti-
SUMO blotting confirmed that SUMO-RanGAP1 at 90 KD wasMoleccoprecipitated with anti-SLP-76 over the time course (lower
panel). SUMO-RanGAP1 selectively associates with the fibrils
of the NPC (Mahajan et al., 1997).
By contrast, anti-SLP-76 failed to precipitate RanBP2
(Nup358) from anti-CD3 activated Jurkat T cells (Figure 1E,
upper panel, lanes 3 and 4), while it coprecipitated SUMO-
RanGAP1 (lower panel, lanes 3 and 4). Anti-RanGAP1 precipi-
tated itself (lower panel, lanes 1 and 2) and RanBP2 (upper panel,
lanes 1 and 2). Similarly, anti-RanGAP1 coprecipitated SLP-76
from 293 T cells transfected with the adaptor (see Figure S1A
available online, upper panel, lane 2 versus lane 1). By contrast,
anti-RanBP2 failed to coprecipitate SLP-76 from 293 T cells ex-
pressing RanBP2 plus SLP-76 (lower panel, lane 4). Likewise,
anti-NFATc1 failed to precipitate SLP-76 or RanGAP1 from
resting or activated Jurkat cells (Figure S1B, lanes 3 and 4).
Anti-SLP-76 coprecipitated RanGAP1, but no NFATc1 (lanes 5
and 6). These observations indicated that SLP-76 bound to
RanGAP1, rather than RanBP2 or NFATc1.
Anti-SLP-76 coprecipitation of RanGAP1 was confirmed by
MALDI-MS/MS (Figure S1C). Colloidal blue staining identified
proteins that were coprecipitated by anti-SLP-76 (upper panel)
that included GADs, ADAP-130 (Fyb-130) and 14-3-3. Six
distinct peptides corresponding to RanGAP1 were detected
(middle and lower boxes).
WealsoobservedSLP-76and theSLP-76/RanGAPcomplex in
biochemically purified nuclear fractions (Figure 1F). Anti-CD3
ligation markedly increased SLP-76 in the nuclear envelope
extract containing theNPC (leftpanel, lanes5and6versus lanes1
and 2). p56lck was enriched in the cytosolic but not nuclear frac-
tion (lower panel, lanes 4 and 8). Further, anti-SLP-76 coprecipi-
tated RanGAP1 from the NPC extract of anti-CD3 ligated cells
(right panel, lane 12). These data confirmed that anti-CD3
increased the presence of SUMO-RanGAP1 in the NPC.
SLP-76 Binding Promotes RanGAP1 Binding and
Function at the NPC
We next mapped RanGAP1 binding to the N terminus of SLP-76
(Figure 2A). RanGAP1was coexpressed with HA-tagged SLP-76
wild-type (WT) or mutants in SLP-76-deficient J14 T cells fol-
lowed by anti-HA precipitation and anti-RanGAP1 blotting.
Anti-CD3 ligation induced the complex formation as shown by
anti-SLP-76 coprecipitation of SUMO-RanGAP1 (lane 2 versus
lane 1). Random mutagenesis showed that mutation of lysine-
56 to glutamic acid (termed K56E) disrupted the interaction
(lanes 3 and 4), while mutation of residues 74/181/491 (i.e.,
3KRE) had no effect (lanes 5 and 6). Blotting of lysates showed
similar RanGAP1 expression in transfected cells (upper inset).
HA-tagged SLP-76 WT and mutant expression was confirmed
by anti-SLP-76 blotting (lower panel). Further, anti-CD3 ligation
increased anti-SLP-76-associated RanGAP1 exchange activity
by 7-fold, an effect lost with mutation of the K56 residue (Fig-
ure 2B). Blotting confirmed the concurrent loss of RanGAP1
binding with K56E (upper inset).
We also assessed whether SLP-76 and binding to RanGAP1
influenced RanGAP1 binding to the NPC. Anti-CD3 ligation
increased SUMO-RanGAP1 coprecipitated by Mab414 (anti-
NPC) over 2–15 min (Figure 2C, upper panel, lanes 3–7 versus
lane 2). Nup62 coprecipitation served as a control (lower panel).ular Cell 59, 840–849, September 3, 2015 ª2015 The Authors 841
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Figure 1. SLP-76 Localizes at the Cytoplasmic Face of the Nuclear Pore Complex and Interacts with SUMO-RanGAP1
(A) Confocal images of mouse DC27.10 T cells stained with Mab414-Alexa Fluor 488, anti-RanGAP1-Alexa Fluor 633, anti-SLP-76-Alexa Fluor 488 and
DAPI (upper and middle panel) (scale bar, 5 mm). TEM images of gold-labeled anti-SLP-76 (yellow arrows) on the cytoplasmic face of the NPC (red dashed
circle) (n = 3).
(B) TEM images of gold-labeled anti-SLP-76 and anti-RanGAP1 (white arrows) relative to the NPC (black arrows) upon anti-CD3 stimulation (left). Histogram
shows distance of SLP-76 and RanGAP1 from central plane of NPC (right).
(C) Anti-SLP-76 coprecipitated RanGAP1. Resting or anti-CD3 activated DC27.10 T cells (left) or human peripheral blood lymphocytes (middle). Precipitation
followed by blotting with anti-RanGAP1 (upper) or anti-SLP-76 (lower) (n = 4). (Right panel) RanGAP1 does not interact with immune adaptors SKAP1, ADAP, or
CARMA1 (n = 3).
(D) Time course of RanGAP1 binding to SLP-76 upon anti-CD3 ligation. Blotted with anti-RanGAP1 (upper panel) or anti-SUMO1 (lower) (n = 3).
(E) Anti-SLP-76 does not coprecipitate RanBP2 from anti-CD3-stimulated Jurkat T cells. Blotted with anti-RanBP2 (upper panel) or anti-RanGAP1 (lower). Also
see Figure S1.
(F) Anti-CD3 increases SLP-76 recruitment to the NPC. Mouse DC27.10 T cells stimulated with anti-CD3 followed by subcellular fractionation and blotted
with anti-SLP-76 (left upper) or anti-lck (left lower). Anti-SLP-76 coprecipitates from NE fraction. Blotted with anti-RanGAP1 (right upper) and anti-SLP-76
(right lower) (n = 4).The increase in coprecipitated SUMO-RanGAP1 from SLP-76-
expressing cells at 15 min postligation (Figure 2D, lane 4 versus
lane 3) was not evident in SLP-76-deficient J14 cells (lane 6
versus lane 5). Similarly, the anti-CD3-induced increase in
SUMO-RanGAP1 in Mab414 precipitates from J14 cells ex-
pressing SLP-76 was not observed from cells with K56E (Fig-
ure 2E, lane 4 versus lane 3 and lane 6 versus lane 5; histogram).
A time course also showed an increase in RanGAP1 that was not
evident in K56E-expressing cells (Figure 2F, lanes 3 and 4 versus842 Molecular Cell 59, 840–849, September 3, 2015 ª2015 The Authlane 2 and lanes 7 and 8 versus lane 6). SLP-76 expression and
SLP-76-RanGAP1 binding is needed for the optimal anti-CD3-
induced association of SUMO-RanGAP1 with the NPC.
We also observed that the specific activity for RanGAP1 for
Ran-GTP was higher in anti-SLP-76 than anti-RanGAP1 precip-
itates lacking SLP-76 (Figure S2A, upper and lower panels).
Specific activities were obtained by normalizing the activity rela-
tive to the amount of RanGAP1 in the precipitates as detected
by blotting. Anti-RanGAP1 precipitates also showed lowerors
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Figure 2. RanGAP1 Binds to SLP-76 Lysine
56 and Regulates RanGAP1 Binding to NPC
(A) RanGAP1 binds to lysine 56 in the SLP-76
N-terminal domain. SLP-76-deficient J14 T cells
cotransfected with HA-tagged SLP-76 or mutants
and mRFP-RanGAP1 (n = 3).
(B) Anti-CD3 increases RanGAP1 exchange activity
that is lost with K56E. (Upper inset) Blot for HA-SLP-
76 wild-type and K56E expression. Data are repre-
sented asmean ± SE of a representative experiment
(n = 3). Also see Figure S2.
(C) Anti-CD3 ligation increases SUMO-RanGAP1
coprecipitated with anti-NPC Mab414. Cell lysates
from DC27.10 T cells were stimulated with anti-CD3
for 15 min, followed by Mab414 precipitation and
blotting with anti-RanGAP1 (upper) or Nup62
(lower) (n = 3).
(D) Anti-CD3-induced increase in SUMO-RanGAP1
association with the NPC is impaired in SLP-76-
deficient T cells (n = 3).
(E) Anti-CD3-induced increase in SUMO-RanGAP1
association with the NPC is impaired in K56E-
expressing cells. Right panel shows histogram of
densitometric readings of SUMO-RanGAP1.
(F) Time course of anti-CD3-induced increase in
SUMO-RanGAP1 coprecipitated by Mab414 from
J14 cells expressing SLP-76 WT or K56E mutant.
Anti-RanGAP1 blot (upper). Anti-SLP-76 blot of cell
lysates (lower) (n = 4).exchange activity from anti-CD3-activated cells expressing
K56E compared to wild-type SLP-76 (Figure S2B). These obser-
vations suggested that, in addition to its role in promoting Ran-
GAP1 binding to the NPC, SLP-76 binding to RanGAP1
increased its GAP activity for Ran-GTP.
SLP-76-RanGAP1 Binding Fails to Affect Proximal
Signaling
It was next important to assess whether the mutation of K56
affected TCR proximal signaling (Figure 3). Microcluster forma-
tion is an early event needed for the stimulation of T cells (Bunnell
et al., 2002; Yokosuka et al., 2005). SLP-76-EYFP and K56E-
EYFP J14 cells were imaged on immobilized anti-CD3 on slides.
Maximum overtime (MOT) images showed the formation and
movement of clusters to central contact area (Figure 3Ai). No dif-
ference was detected between WT and K56E in terms of the
number (ii), speed (iii), size (iv), or migration of clusters (v) (Movie
S1). K56E and wild-type SLP-76 also bound to similar amounts
of ADAP, GADS, and PLCg1 (Figure 3B). In both cases, PLCg1
shifted in migration in response to anti-CD3, consistent with
increased phosphorylation. Anti-CD3-induced increase in intra-
cellular calcium was also the same in J14 cells expressing
K56E and WT SLP-76 (Figures 3C and S3A). The ionomycin-
induced increase was also the same in SLP-76 WT and K56E-
transfected cells (right panels).
NFATc1 dephosphorylation by calcineurin is a prerequisite for
its nuclear translocation (Crabtree and Olson, 2002; Jain et al.,
1992). J14 cells expressing K56E and WT SLP-76 showed a
similar decrease in phosphorylated versus dephosphorylated
NFAT in response to anti-CD3 ligation (Figure 3D). Further, a
measurement of calcineurin phosphatase activity showed aMolecsimilar increase in K56E and WT SLP-76-expressing cells (data
not shown). These data indicated that K56E had no obvious
effect on key aspects of proximal signaling by SLP-76.
SLP-76-RanGAP1 Binding Is Needed for Optimal
NFATc1 and Rel/p65 Nuclear Entry
Despite having no effect on proximal signaling, the K56E mutant
impaired NFATc1 entry into the nucleus. GFP-tagged NFATc1
nuclear translocation was imaged in J14 T cells expressing
wild-type and K56E SLP-76 (Figure 4A). Transfected cells were
incubated with anti-CD3 or isotype control (resting) for 5 min fol-
lowed by anti-HA-Alexa Fluor 633 staining. Cells were scored
positive when >70% of total GFP-NFATc1 overlapped with
DAPI nuclear staining as quantified by ImageJ (Figure 4A, upper
images; Figure S3B). Anti-HA staining was used as an internal
control for WT or K56E HA-SLP-76 expression. While 45% of
SLP-76-expressing cells showed nuclear NFATc1-GFP in
response to anti-CD3, only 18% of cells expressing the K56E
showed nuclear entry (Figure 4A, lower histogram). These data
showed that SLP-76–RanGAP1 is needed for optimal anti-CD3-
induced NFATc1 nuclear entry. K56E also impaired anti-CD3-
induced transcription of an NFAT-driven IL-2 reporter construct
by 50%–60% at different anti-CD3 concentrations (Figure 4B).
Coexpression of SLP-76 and RanGAP1 also synergised to
enhance anti-CD3-induced NFATc1 transcription, an effect
impaired by K56E (Figure S4A). Anti-SLP-76 blotting confirmed
similar transfected SLP-76wild-type andK56E expression, com-
parable to endogenous SLP-76 in Jurkat cells (upper left inset).
Anti-HA-blotting showed similar RanGAP1 expression in trans-
fected cells including the higher MW SUMO-RanGAP1 (upper
right panel). As a control, mRFP-RanGAP1 transfection showedular Cell 59, 840–849, September 3, 2015 ª2015 The Authors 843
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Figure 3. SLP-76 K56E Does Not Interfere with Early TCR Signaling Events
(A) K56E does not interfere with clustering. EYFP-SLP-76WT and EYFP-SLP-76 K56Emutant cluster formation in Jurkat J14 cells on anti-CD3 coated coverslides
(0–125 s). (i) Maximum overtime images; (ii) average number of microclusters; (iii) mean speed of EYFP-SLP-76 WT (black dots) and EYFP-SLP-76 K56E (white
dots) clusters; (iv) size of microclusters; (v) trafficking analysis (n = 3).
(B) SLP-76 K56E associates normally with ADAP, GADS, and PLCg1. J14 cells transfected with HA-SLP-76WT or HA-SLP-76 K56E were stimulated by anti-CD3
followed by precipitation with anti-SLP-76 and blotting (n = 3).
(C) K56E supports calcium mobilization. Intracellular calcium levels were measured in J14 T cells transfected with HA-SLP-76 WT or HA-SLP-76 K56E mutant
upon anti-CD3 stimulation (left) or ionomycin treatment (right) (n = 4). Also related to Figure S3A.
(D)SLP-76WT-andSLP-76K56E-expressingcells show thesame levels ofNFATc1dephosphorylation. TransfectedasaboveandstimulatedwithPMA/ionomycin,
or anti-CD3 for various times followed by blotting with anti-NFAT1c1 (left) (n = 3). Histogram shows the similar decreasing phospho-NFATc1/NFATc1 ratio (right).exclusive localization to the cytoplasm (Figure S4B). K56E
expression also impairedNFAT transcription inducedby ionomy-
cin/phorbol ester (PMA), indicating that the SLP-76-RanGAP1
was needed for NFAT transcription induced by receptor-inde-
pendent activation (Figure S4C). Intracellular staining for IL-2
also showed its reduced presence in SLP-76 K56E-expressing
cells (Figure S4D).
SLP-76 K56E also inhibited the translocation of transport of
NFkB p65/RelA into the nucleus (Figure 4C). GFP-RelA/p65
and HA-SLP-76 were cotransfected into J14 Jurkat cells, stimu-
lated with anti-CD3, and imaged by confocal microscopy. SLP-
76 K56E showed a reduction of 45% of GFP-RelA/p65 nuclear
entry at 5 min and 65% at 15 min relative to WT SLP-76 (upper
panels and lower histogram). Similar levels of GFP-RelA/p65
were expressed in cells with HA-SLP-76 WT and K56E (inset).
Consistently, the anti-CD3-induced NF-kB driven luciferase re-
porter activity was 50%–60% lower in cells expressing K56E
SLP-76 compared to WT SLP-76 (Figure 4D).844 Molecular Cell 59, 840–849, September 3, 2015 ª2015 The AuthSLP-76-RanGAP1 Binding Is Needed for Optimal T Cell
In Vivo Responses to Antigen
Given this, we next assessed whether the SLP-76-RanGAP1
interaction affected T cell responses in vivo (Figure 4E).
DO11.10 transgenic T cells were transfected with either
SLP-76-K56E or WT SLP-76, labeled with CFSE, and injected
i.v. into Balb/c mice. Twenty-four hours later, 50 mg OVA
peptide was then injected i.v. into mice (Greenwald et al.,
2001). On day 6, spleens were extracted for FACs analysis
(upper panel). Intracellular staining confirmed similar SLP-76
and K56E expression (middle panel). HA-SLP-76 was ex-
pressed similar to endogenous SLP-76 (inset). We found
that while HA-SLP-76 WT supported OVA peptide-induced
T cell proliferation, K56E-expressing cells were markedly
impaired in their in vivo response to peptide (lower panel).
These data confirmed that the SLP-76-RanGAP1 interaction
plays a significant role in in vivo responses of T cells to
antigen.ors
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Figure 4. RanGAP1-SLP-76 Is Needed for Optimal NFATc1 and p65/RelA Nuclear Entry and In Vivo Responses to Antigen
(A) SLP-76 K56E shows impaired anti-CD3-induced-NFATc1 nuclear translocation. Images of cytoplasmic and nuclear GFP-NFATc in J14 T cells expressing
HA-SLP-76 WT or HA-SLP-76 K56E. (Upper panel) Example of lines that delineate DAPI stained nucleus (white dotted line) from total cell (red dotted line). Also
see Figure S3B. Histogram showing percentage of cells with nuclear NFATc1 (lower). Data are represented as a means of ± SD from a representative
experiment (n = 3).
(B) SLP-76 K56E impairs anti-CD3-induced NFAT transcription activity. Anti-CD3 activation of Jurkat J14 cells with SLP-76 WT or SLP-76 K56E and NFAT (3x)
luciferase reporter. (Inset) Expression levels of transfected SLP-76WT and mutant K56E. Data are means of ± SD from a representative experiment (n = 4).
(C) SLP-76 K56E impairs NFkB p65 (RelA) nuclear entry. Anti-CD3 stimulated J14 Jurkat cells expressing GFP-RelA/p65 and HA-SLP-76 or HA-K56E. Image of
cells with SLP-76 (upper) or K56E (middle). Histogram showing percentage GFP-p65/RelA entry into nucleus (lower). (Upper inset) Blotting with anti-GFP show
equal GFP-RelA/p65 in SLP-76 WT and K56E cells.
(D) Luciferase NF-kB reporter levels impaired in K56E-expressing J14 cells. Cells were transfected with SLP-76 or K56E plus a luciferase NF-kB reporter
construct of interleukin 2 promoter. Data are means of ± SD from a representative experiment (n = 2). Also see Figure S4.
(E) RanGAP1-SLP-76 binding is needed for optimal in vivo responses of DO11.10 T cells to OVA peptide. CFSE-labeled DO11.10 CD4+ T cells were i.v. injected
into the tail of Balb/c mice, followed by I.V. injection of 50 ug OVA- peptide 24 hr later. Experimental design (upper). Intracellular staining of transfected cells for
SLP-76 wild-type and K56E (middle). (Inset) Anti-SLP-76 blotting of cell lysate showed that the level of expressed HA-SLP-76 is similar to endogenous SLP-76.
Proliferation as measured by FACs analysis of CFSE intensity at day 6 (percentage CFSE low relative to total CFSE) (lower). Data are means of ± SD from
representative experiments. Differences between means were tested using two-tailed unpaired Student’s t test; *p < 0.05 was considered significant.DISCUSSION
Although the NPC controls the entry of transcription factors into
nucleus in response to antigen receptor ligation on T cells, it has
been unclear whether cytoplasmic adaptors directly modulate
the NPC. The cytoplasmic localization of NPC filaments makesMolecthem ideal targets. Our findings now identify immune cell
adaptor SLP-76 binding to SUMO-RanGAP1 of the NPC as a
mechanism to ensure the optimal transport of NFATc1 and
RelA/p65 in the nucleus in response to antigen-receptor ligation.
We found that this surprising interaction accounts for at least
40%–50% of NFATc1 and NF-kB p65 entry into nucleus ofular Cell 59, 840–849, September 3, 2015 ª2015 The Authors 845
T cells. The interaction represents a second checkpoint for
NFATc1 nuclear entry, and may reflect the immense pressure
on T cells to induce a rapid response to infection.
SLP-76 bound to RanGAP1, an event increased by TCR anti-
gen receptor ligation. The principle form was SUMO-RanGAP1
that is exclusively associated with NPC filaments. SUMO1 is
added to residue K526 of RanGAP1 and regulates the Ran-
GDP-GTP gradient for importin a/b-dependent nuclear import
(Mahajan et al., 1998). Specificity was shown by the failure of
antibodies to ADAP, SKAP1, and CARMA1 to coprecipitate
RanGAP1. SLP-76-SUMO-RanGAP1 was seen in mouse and
human cell lines and primary cells, and appeared to occur maxi-
mally as a later event following TCR ligation. Its presence was
confirmed by mass spectrometry after a late activation period,
but is less evident in precipitates from T cells activated over
shorter periods (Roncagalli et al., 2014). Remarkably, TEM
showed that 76% of NPCs had at least one gold particle of
SLP-76 with an average distance of 35 nm from the cytoplasmic
face of the NPC, a distance comparable to RanGAP1. We found
that binding depended on lysine 56 in SLP-76, where itsmutation
caused a loss of RanGAP1 binding and associatedGTP/GDP ex-
change activity. Whether posttranslational modifications to K56
such as SUMOylation facilitate the interaction is unclear. Prelim-
inary results with MaxQuant matching and Q-exactive failed to
show SUMOylation (data not shown). SLP-76 therefore inter-
faces with the NPC complex by binding to SUMO-RanGAP1 of
the cytoplasmic filaments of the pore complex.
Mechanistically, anti-CD3 ligation increased SLP-76 binding
to RanGAP1 as well as GAP activity and complex binding to
the NPC, in accord with the TEM studies. Antigen receptor mod-
ulation of RanGAP1 activity has not been previously reported.
Further, SLP-76 affected RanGAP1 by acting on its binding to
the NPC and GTP-GDP exchange activity. J14 cells lacking
SLP-76, or transfected with K56E, had reduced coprecipitated
RanGAP1 with MAb414, and lower RanGAP1 activity when
normalized to levels of coprecipitated protein. It was the anti-
CD3 stimulated increase (rather than basal activity) that was
affected by SLP-76 deficiency, or the K56E mutant. The
enhanced presence and activity of RanGAP1 at the NPC are in
keeping with its role in regulating the Ran-GDP/GTP gradient
(Quimby and Dasso, 2003).
Importantly, we showed that the SLP-76-RanGAP1 regulated
the nuclear entry of two key transcription factors, NFATc1 and
NF-kB p65. K56E impaired entry of each to the same degree.
Further, SLP-76 and RanGAP1 synergized to greatly enhance
anti-CD3-induced NFAT-driven transcription, an effect lost with
the K56E mutant. Importantly, K56E had no effect on proximal
signaling events such as SLP-76microcluster formation, calcium
mobilization, or NFATc1 dephosphorylation. Despite this, the
K56E mutant impaired NFATc1-GFP and GFP-RelA/p65 nuclear
entry and transcription by 40%–50%. An evenmore pronounced
effect was observed in the in vivo responses of DO11.10 T cells
to OVA peptide. NFAT entry therefore involves two steps, canon-
ical dephosphorylation followed by direct SLP-76 binding to
RanGAP1 and regulation at the NPC. This second tier of regula-
tion may reflect the need for rapid transcription to respond to in-
fections by viruses and other pathogens. The full range of cargo
and the different receptors (i.e., innate versus adaptive) involved846 Molecular Cell 59, 840–849, September 3, 2015 ª2015 The Authin the pathway remains to be determined. However, a broad
effect on signaling was suggested by K56E inhibition of recep-
tor-independent stimulation by PMA/ionomycin.
The SLP-76-SUMO-RanGAP1 interaction is unique to im-
mune cells and has evolved to complement generic NPC regu-
lation by RanBP2 that helps to localize SUMO1-RanGAP1 and
UBC9 at the NPC. SLP-76 bound to RanGAP1, but not RanBP2,
suggesting that SLP-76 is likely to complement RanBP2.
Further, K56E preferentially affected the TCR/CD3 increase
in the RanGAP1-NPC association in accord with a specific
connection to TCR signaling. Whether SLP-76 homologs with
a similar function exist in other cell types such as neuron cells
remains to be determined.
Whether SLP-76 is derived from the cell surface or a distinct
pool is unclear. SLP-76 microclusters accumulate in a perinu-
clear structure (Bunnell et al., 2002). It is also a later event, peak-
ing at 15–20 min postligation, consistent with time needed to
move from the cell surface to the nucleus. We postulate that
SLP-76 surface clusters may eventually migrate and regulate
the NPC. Alternatively, a separate pool of compartmentalised
SLP-76 could also interact. Future studies will determine the
range of cargo regulated by the SLP-76-RanGAP1 complex
and whether it is needed for nuclear entry induced by other re-
ceptors such as Toll-like receptors (TLRs).
EXPERIMENTAL PROCEDURES
Cell Culture and Reagents
Jurkat, SLP-76-deficient J14, T8.1, and DC27.10 cells were cultured as previ-
ously described (Liu et al., 2010; Raab et al., 1999; Schneider et al., 2008).
Antibodies included anti-human CD3 (OKT3), hamster anti-mouse CD3 145-
2C11 (ATCC), anti-SLP-76 (BioXcell, West Lebanon, NH), anti-RanGAP1
(Santa Cruz Biotechnology, USA), Mab414 (Covance), anti-SUMO1 (gift from
R. Hay, Dundee, UK), anti-Carma1 (Cell Signaling USA), anti-HA (Covance),
anti-Lck, anti-ADAP, anti-SKAP1, and anti-GADS (Upstate Biotechnology,
USA), anti-NF-ATc1 (Santa Cruz Biotechnology, Santa Cruz, CA, USA), anti-
RanBP2 (Thermo Scientific), and anti-actin (Sigma-Aldrich, USA). Carboxy-
fluorescein diacetate succinimidyl ester (CFSE) was purchased from Sigma
(Poole, UK). HA-tagged SLP-76 and RanGAP1, SLP-76-YFP, and the K56E
SLP-76 mutant were constructed as described in the Supplemental Experi-
mental Procedures.
Transfection and Stimulation
Mouse and human T cells were stimulated with 2–5 mg/ml of 145-2C11 or
OKT3 as described (Raab et al., 1999). Jurkat and J14 T cells were transfected
by microporation (Digital Bio Technology) using a single pulse of 30 ms at
1410 V, while DC27.10 cells received 2 pulses of 20 ms at 1,400 V. Human
primary T cells were transfected using a single pulse of 20 ms at 2,259 V. Pri-
mary naivemouse cells were transfectedwith various vectors using the Amaxa
Nucleofector Kit (Lonza, Germany).
RanGAP1 GAP Activity Assays
RanGAP1 activity was quantified using either a Phos-Free Phosphate Assay
Kit (Cytoskeleton Inc., Denver, CO) or a radioactive assay as described in
Bischoff et al. (1994) and in the Supplemental Experimental Procedures.
RanGAP1 GAP activity measured by isotope labeling (Figures 2B and S2A),
or using a nonradioactive protocol (Figure S2B), **p < 0.01, ***p < 0.001 versus
SLP-76 WT. The average results were shown from three independent
experiments.
Immune Precipitation and Nuclear Pore Fraction
Precipitation and blotting were performed as described (Raab et al., 2011). Nu-
clear pore fractions were separated from cytoplasmic fractions of DC27.10ors
T cells by using the Thermo NE-PER Nuclear and Cytoplasmic Extraction Kit
(Fischer Scientific).
Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS)
Bands from anti-SLP-76 precipitation from DC27.10 or T8.1 T cells were
analyzed by liquid chromatography-tandem mass spectrometry (LC-MS/MS)
(conducted by Cambridge Centre for Proteomics, Cambridge University) as
described in the Supplemental Experimental Procedures. Database searches
of the mass fingerprint data were performed using Mascot (http://www.
matrixscience.com). For tandem ms/ms analysis, desalted peptides were
delivered to a ThermoFinnigan LCQ Classic ion-trap mass spectrometer using
a static nanospray needle (Thermo Proxeon). Fragment ions were matched to
possible sequence interpretations using MS-Product and/or MS-Tag (http://
prospector.ucsf.edu/).
Immunofluorescence and Confocal Imaging
Immunofluorescence and confocal imaging were conducted as previously
described (Liu et al., 2010; Purbhoo et al., 2010) and as described in the
Supplemental Experimental Procedures. J14 cells were cotransfected with
GFP-NFATc1 or GFP-RelA/p65 together with either HA-SLP-76 WT or HA-
SLP76 K56E.
In Vivo Adoptive T Cell Transfer Assay
Adoptive T cell transfer assay were conducted as described in the Supple-
mental Experimental Procedures. DO11.10 T cells were transfected with HA-
SLP-76 or HA-SLP-76 K53E and labeled with CFSE (5 mM). Proliferation of
CFSE labeled T cells was assessed 6 days after the OVA-peptide injections
by FACs analysis.
Transmission Electron Microscopy
TEMwas conducted as described (Zuleger et al., 2011). Images were taken on
a Hitachi H7600 electron microscope. In order to measure the distances, since
the cytoplasmic ring could not be directly visualized, first the distance from the
central plane to the particle was measured, then the known distance (40 nm)
from the central plane to the top of the cytoplasmic ring (Maimon et al.,
2012) was subtracted to give the ring-label distance.
Measurement of Intracellular Calcium
SLP-76-deficient J14 cells transfected with pcDNA-SLP-76 WT or K56E
mutant were subjected to calcium influx measurement with Indo-1 (Invitrogen)
(Parry et al., 2000). For statistical comparisons, the calcium response was
normalized and expressed as the ratio of the maximum peak poststimulation
to baseline. Kinetic plots were generated on ligated (Indo-1-labeled) cells
using FlowJo software.
Promoter Reporter Assays
Promoter Reporter Assays were conducted as previously described (Liu et al.,
2010; Raab et al., 1999; Veale et al., 1999) and as described in the Supple-
mental Experimental Procedures. Luciferase activity was measured using a
luminometer (MicroLumat, EG&G Berthold).
SUPPLEMENTAL INFORMATION
Supplemental Information includes four figures, one movie, and Supplemental
Experimental Procedures and can be found with this article at http://dx.doi.
org/10.1016/j.molcel.2015.07.015.
AUTHOR CONTRIBUTIONS
C.E.R. conceived of the original basis of the project and coordinated the
activities of coauthors; H.L. and H.S. carried out the biochemical, cellular
and imaging studies; A.R. carried out GAP assays and imaging studies;
H.L., C.R., and M.W.G. conducted the transmission electron microscopy;
C.E.R and H.L. wrote the manuscript with contributions from H.S., A.R.,
C.R., and M.W.G.MolecACKNOWLEDGMENTS
Thework was supported by the program grant fromWellcome Trust 092627/Z/
10/Z (C.E.R.).
Received: October 23, 2014
Revised: June 1, 2015
Accepted: July 17, 2015
Published: August 27, 2015
REFERENCES
Allen, T.D., Rutherford, S.A., Murray, S., Drummond, S.P., Goldberg, M.W.,
and Kiseleva, E. (2008). Scanning electron microscopy of nuclear structure.
Methods Cell Biol. 88, 389–409.
Bernier-Villamor, V., Sampson, D.A., Matunis, M.J., and Lima, C.D. (2002).
Structural basis for E2-mediated SUMO conjugation revealed by a complex
between ubiquitin-conjugating enzyme Ubc9 and RanGAP1. Cell 108,
345–356.
Bischoff, F.R., Klebe, C., Kretschmer, J., Wittinghofer, A., and Ponstingl, H.
(1994). RanGAP1 induces GTPase activity of nuclear Ras-related Ran. Proc.
Natl. Acad. Sci. USA 91, 2587–2591.
Bubeck Wardenburg, J., Fu, C., Jackman, J.K., Flotow, H., Wilkinson, S.E.,
Williams, D.H., Johnson, R., Kong, G., Chan, A.C., and Findell, P.R. (1996).
Phosphorylation of SLP-76 by the ZAP-70 protein-tyrosine kinase is required
for T-cell receptor function. J. Biol. Chem. 271, 19641–19644.
Bubeck Wardenburg, J., Pappu, R., Bu, J.Y., Mayer, B., Chernoff, J., Straus,
D., and Chan, A.C. (1998). Regulation of PAK activation and the T cell cytoskel-
eton by the linker protein SLP-76. Immunity 9, 607–616.
Bunnell, S.C., Diehn, M., Yaffe, M.B., Findell, P.R., Cantley, L.C., andBerg, L.J.
(2000). Biochemical interactions integrating Itk with the T cell receptor-initiated
signaling cascade. J. Biol. Chem. 275, 2219–2230.
Bunnell, S.C., Hong, D.I., Kardon, J.R., Yamazaki, T., McGlade, C.J., Barr,
V.A., and Samelson, L.E. (2002). T cell receptor ligation induces the formation
of dynamically regulated signaling assemblies. J. Cell Biol. 158, 1263–1275.
Chatel, G., and Fahrenkrog, B. (2012). Dynamics and diverse functions of nu-
clear pore complex proteins. Nucleus 3, 162–171.
Crabtree, G.R., and Olson, E.N. (2002). NFAT signaling: choreographing the
social lives of cells. Cell 109 (Suppl ), S67–S79.
D’Angelo, M.A., and Hetzer, M.W. (2008). Structure, dynamics and function of
nuclear pore complexes. Trends Cell Biol. 18, 456–466.
da Silva, A.J., Li, Z., de Vera, C., Canto, E., Findell, P., and Rudd, C.E. (1997).
Cloning of a novel T-cell protein FYB that binds FYN and SH2-domain-contain-
ing leukocyte protein 76 and modulates interleukin 2 production. Proc. Natl.
Acad. Sci. USA 94, 7493–7498.
Di Bartolo, V., Montagne, B., Salek, M., Jungwirth, B., Carrette, F., Fourtane,
J., Sol-Foulon, N., Michel, F., Schwartz, O., Lehmann, W.D., and Acuto, O.
(2007). A novel pathway down-modulating T cell activation involves HPK-1-
dependent recruitment of 14-3-3 proteins on SLP-76. J. Exp. Med. 204,
681–691.
Ghosh, S., and Karin, M. (2002). Missing pieces in the NF-kappaB puzzle. Cell
109 (Suppl ), S81–S96.
Grasis, J.A., Guimond, D.M., Cam, N.R., Herman, K., Magotti, P., Lambris,
J.D., and Tsoukas, C.D. (2010). In vivo significance of ITK-SLP-76 interaction
in cytokine production. Mol. Cell. Biol. 30, 3596–3609.
Greenwald, R.J., Boussiotis, V.A., Lorsbach, R.B., Abbas, A.K., and Sharpe,
A.H. (2001). CTLA-4 regulates induction of anergy in vivo. Immunity 14,
145–155.
Hoelz, A., Debler, E.W., and Blobel, G. (2011). The structure of the nuclear pore
complex. Annu. Rev. Biochem. 80, 613–643.
Hutten, S., Flotho, A., Melchior, F., and Kehlenbach, R.H. (2008). The Nup358-
RanGAP complex is required for efficient importin alpha/beta-dependent nu-
clear import. Mol. Biol. Cell 19, 2300–2310.ular Cell 59, 840–849, September 3, 2015 ª2015 The Authors 847
Jackman, J.K., Motto, D.G., Sun, Q., Tanemoto, M., Turck, C.W., Peltz, G.A.,
Koretzky, G.A., and Findell, P.R. (1995). Molecular cloning of SLP-76, a 76-kDa
tyrosine phosphoprotein associated with Grb2 in T cells. J. Biol. Chem. 270,
7029–7032.
Jain, J., McCaffrey, P.G., Valge-Archer, V.E., and Rao, A. (1992). Nuclear fac-
tor of activated T cells contains Fos and Jun. Nature 356, 801–804.
Jordan, M.S., Singer, A.L., and Koretzky, G.A. (2003). Adaptors as central
mediators of signal transduction in immune cells. Nat. Immunol. 4, 110–116.
Lee, G.W., Melchior, F., Matunis, M.J., Mahajan, R., Tian, Q., and Anderson, P.
(1998). Modification of Ran GTPase-activating protein by the small ubiquitin-
related modifier SUMO-1 requires Ubc9, an E2-type ubiquitin-conjugating
enzyme homologue. J. Biol. Chem. 273, 6503–6507.
Liu, J., Kang, H., Raab, M., da Silva, A.J., Kraeft, S.K., and Rudd, C.E. (1998).
FYB (FYN binding protein) serves as a binding partner for lymphoid protein and
FYN kinase substrate SKAP55 and a SKAP55-related protein in T cells. Proc.
Natl. Acad. Sci. USA 95, 8779–8784.
Liu, H., Purbhoo, M.A., Davis, D.M., and Rudd, C.E. (2010). SH2 domain con-
taining leukocyte phosphoprotein of 76-kDa (SLP-76) feedback regulation of
ZAP-70 microclustering. Proc. Natl. Acad. Sci. USA 107, 10166–10171.
Mahajan, R., Delphin, C., Guan, T., Gerace, L., and Melchior, F. (1997). A small
ubiquitin-related polypeptide involved in targeting RanGAP1 to nuclear pore
complex protein RanBP2. Cell 88, 97–107.
Mahajan, R., Gerace, L., and Melchior, F. (1998). Molecular characterization of
the SUMO-1 modification of RanGAP1 and its role in nuclear envelope asso-
ciation. J. Cell Biol. 140, 259–270.
Maimon, T., Elad, N., Dahan, I., and Medalia, O. (2012). The human nuclear
pore complex as revealed by cryo-electron tomography. Structure 20, 998–
1006.
Marinari, B., Costanzo, A., Viola, A., Michel, F., Mangino, G., Acuto, O.,
Levrero, M., Piccolella, E., and Tuosto, L. (2002). Vav cooperates with CD28
to induce NF-kappaB activation via a pathway involving Rac-1 and mitogen-
activated kinase kinase 1. Eur. J. Immunol. 32, 447–456.
Matunis, M.J., Coutavas, E., and Blobel, G. (1996). A novel ubiquitin-like modi-
fication modulates the partitioning of the Ran-GTPase-activating protein
RanGAP1 between the cytosol and the nuclear pore complex. J. Cell Biol.
135, 1457–1470.
Melchior, F., Guan, T., Yokoyama, N., Nishimoto, T., and Gerace, L. (1995).
GTP hydrolysis by Ran occurs at the nuclear pore complex in an early step
of protein import. J. Cell Biol. 131, 571–581.
Mu¨ller, M.R., and Rao, A. (2010). NFAT, immunity and cancer: a transcription
factor comes of age. Nat. Rev. Immunol. 10, 645–656.
Musci, M.A., Hendricks-Taylor, L.R., Motto, D.G., Paskind, M., Kamens, J.,
Turck, C.W., and Koretzky, G.A. (1997). Molecular cloning of SLAP-130, an
SLP-76-associated substrate of the T cell antigen receptor-stimulated protein
tyrosine kinases. J. Biol. Chem. 272, 11674–11677.
Parry, C.M., Simas, J.P., Smith, V.P., Stewart, C.A., Minson, A.C., Efstathiou,
S., and Alcami, A. (2000). A broad spectrum secreted chemokine binding pro-
tein encoded by a herpesvirus. J. Exp. Med. 191, 573–578.
Pichler, A., Gast, A., Seeler, J.S., Dejean, A., and Melchior, F. (2002). The nu-
cleoporin RanBP2 has SUMO1 E3 ligase activity. Cell 108, 109–120.
Pivniouk, V., Tsitsikov, E., Swinton, P., Rathbun, G., Alt, F.W., and Geha, R.S.
(1998). Impaired viability and profound block in thymocyte development in
mice lacking the adaptor protein SLP-76. Cell 94, 229–238.
Purbhoo, M.A., Liu, H., Oddos, S., Owen, D.M., Neil, M.A., Pageon, S.V.,
French, P.M., Rudd, C.E., and Davis, D.M. (2010). Dynamics of subsynaptic
vesicles and surface microclusters at the immunological synapse. Sci.
Signal. 3, ra36.
Quimby, B.B., and Dasso, M. (2003). The small GTPase Ran: interpreting the
signs. Curr. Opin. Cell Biol. 15, 338–344.
Raab, M., da Silva, A.J., Findell, P.R., and Rudd, C.E. (1997). Regulation of
Vav-SLP-76 binding by ZAP-70 and its relevance to TCR zeta/CD3 induction
of interleukin-2. Immunity 6, 155–164.848 Molecular Cell 59, 840–849, September 3, 2015 ª2015 The AuthRaab, M., Kang, H., da Silva, A., Zhu, X., and Rudd, C.E. (1999). FYN-T-FYB-
SLP-76 interactions define a T-cell receptor zeta/CD3-mediated tyrosine
phosphorylation pathway that up-regulates interleukin 2 transcription in
T-cells. J. Biol. Chem. 274, 21170–21179.
Raab,M.,Wang, H., Lu, Y., Smith, X.,Wu, Z., Strebhardt, K., Ladbury, J.E., and
Rudd, C.E. (2010). T cell receptor ‘‘inside-out’’ pathway via signaling module
SKAP1-RapL regulates T cell motility and interactions in lymph nodes.
Immunity 32, 541–556.
Raab,M., Smith, X., Matthes, Y., Strebhardt, K., and Rudd, C.E. (2011). SKAP1
PH domain determines RAPL membrane localization and Rap1 complex for-
mation for TCR activation of LFA-1. J. Biol. Chem. 286, 29663–29670.
Roncagalli, R., Hauri, S., Fiore, F., Liang, Y., Chen, Z., Sansoni, A., Kanduri, K.,
Joly, R., Malzac, A., La¨hdesma¨ki, H., et al. (2014). Quantitative proteomics
analysis of signalosome dynamics in primary T cells identifies the surface re-
ceptor CD6 as a Lat adaptor-independent TCR signaling hub. Nat. Immunol.
15, 384–392.
Rudd, C.E. (1999). Adaptors and molecular scaffolds in immune cell signaling.
Cell 96, 5–8.
Rudd, C.E., Trevillyan, J.M., Dasgupta, J.D.,Wong, L.L., and Schlossman, S.F.
(2010). Pillars article: the CD4 receptor is complexed in detergent lysates to a
protein-tyrosine kinase (pp58) from human T lymphocytes. 1988. J. Immunol.
185, 2645–2649.
Samelson, L.E. (2002). Signal transduction mediated by the T cell antigen re-
ceptor: the role of adapter proteins. Annu. Rev. Immunol. 20, 371–394.
Schneider, H., Guerette, B., Guntermann, C., and Rudd, C.E. (2000). Resting
lymphocyte kinase (Rlk/Txk) targets lymphoid adaptor SLP-76 in the cooper-
ative activation of interleukin-2 transcription in T-cells. J. Biol. Chem. 275,
3835–3840.
Schneider, H., Smith, X., Liu, H., Bismuth, G., and Rudd, C.E. (2008). CTLA-4
disrupts ZAP70 microcluster formation with reduced T cell/APC dwell times
and calcium mobilization. Eur. J. Immunol. 38, 40–47.
Sen, R. (2011). The origins of NF-kB. Nat. Immunol. 12, 686–688.
Shibasaki, F., Price, E.R., Milan, D., and McKeon, F. (1996). Role of kinases
and the phosphatase calcineurin in the nuclear shuttling of transcription factor
NF-AT4. Nature 382, 370–373.
Shui, J.W., Boomer, J.S., Han, J., Xu, J., Dement, G.A., Zhou, G., and Tan, T.H.
(2007). Hematopoietic progenitor kinase 1 negatively regulates T cell receptor
signaling and T cell-mediated immune responses. Nat. Immunol. 8, 84–91.
Smith-Garvin, J.E., Koretzky, G.A., and Jordan, M.S. (2009). T cell activation.
Annu. Rev. Immunol. 27, 591–619.
Thaker, Y.R., Schneider, H., and Rudd, C.E. (2015). TCR andCD28 activate the
transcription factor NF-kB in T-cells via distinct adaptor signaling complexes.
Immunol. Lett. 163, 113–119.
Veale, M., Raab, M., Li, Z., da Silva, A.J., Kraeft, S.K., Weremowicz, S.,
Morton, C.C., and Rudd, C.E. (1999). Novel isoform of lymphoid adaptor
FYN-T-binding protein (FYB-130) interacts with SLP-76 and up-regulates
interleukin 2 production. J. Biol. Chem. 274, 28427–28435.
Wang, H., and Rudd, C.E. (2008). SKAP-55, SKAP-55-related and ADAP adap-
tors modulate integrin-mediated immune-cell adhesion. Trends Cell Biol. 18,
486–493.
Werner, A., Flotho, A., andMelchior, F. (2012). The RanBP2/RanGAP1*SUMO1/
Ubc9 complex is a multisubunit SUMO E3 ligase. Mol. Cell 46, 287–298.
Williamson, D.J., Owen, D.M., Rossy, J., Magenau, A., Wehrmann, M.,
Gooding, J.J., and Gaus, K. (2011). Pre-existing clusters of the adaptor Lat
do not participate in early T cell signaling events. Nat. Immunol. 12, 655–662.
Wu, J., Motto, D.G., Koretzky, G.A., and Weiss, A. (1996). Vav and SLP-76
interact and functionally cooperate in IL-2 gene activation. Immunity 4,
593–602.
Wu, H., Peisley, A., Graef, I.A., and Crabtree, G.R. (2007). NFAT signaling and
the invention of vertebrates. Trends Cell Biol. 17, 251–260.ors
Yablonski, D., Kuhne, M.R., Kadlecek, T., and Weiss, A. (1998). Uncoupling of
nonreceptor tyrosine kinases from PLC-gamma1 in an SLP-76-deficient T cell.
Science 281, 413–416.
Yablonski, D., Kadlecek, T., and Weiss, A. (2001). Identification of a phospho-
lipase C-gamma1 (PLC-gamma1) SH3 domain-binding site in SLP-76 required
for T-cell receptor-mediated activation of PLC-gamma1 and NFAT. Mol. Cell.
Biol. 21, 4208–4218.
Yokosuka, T., Sakata-Sogawa, K., Kobayashi, W., Hiroshima, M., Hashimoto-
Tane, A., Tokunaga, M., Dustin, M.L., and Saito, T. (2005). Newly generatedMolecT cell receptor microclusters initiate and sustain T cell activation by recruit-
ment of Zap70 and SLP-76. Nat. Immunol. 6, 1253–1262.
Zhang, W., Sloan-Lancaster, J., Kitchen, J., Trible, R.P., and Samelson, L.E.
(1998). LAT: the ZAP-70 tyrosine kinase substrate that links T cell receptor
to cellular activation. Cell 92, 83–92.
Zuleger, N., Kelly, D.A., Richardson, A.C., Kerr, A.R., Goldberg, M.W.,
Goryachev, A.B., and Schirmer, E.C. (2011). System analysis shows distinct
mechanisms and common principles of nuclear envelope protein dynamics.
J. Cell Biol. 193, 109–123.ular Cell 59, 840–849, September 3, 2015 ª2015 The Authors 849
